Definitive Healthcare Corp Stock Alpha and Beta Analysis
| DH Stock | USD 4.45 0.08 1.83% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Definitive Healthcare Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in Definitive Healthcare over a specified time horizon. Remember, high Definitive Healthcare's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Definitive Healthcare's market risk premium analysis include:
Beta 1.91 | Alpha (0.17) | Risk 2.59 | Sharpe Ratio 0.0086 | Expected Return 0.0223 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Definitive |
Definitive Healthcare Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Definitive Healthcare market risk premium is the additional return an investor will receive from holding Definitive Healthcare long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Definitive Healthcare. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Definitive Healthcare's performance over market.| α | -0.17 | β | 1.91 |
Definitive Healthcare expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Definitive Healthcare's Buy-and-hold return. Our buy-and-hold chart shows how Definitive Healthcare performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Definitive Healthcare Market Price Analysis
Market price analysis indicators help investors to evaluate how Definitive Healthcare stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Definitive Healthcare shares will generate the highest return on investment. By understating and applying Definitive Healthcare stock market price indicators, traders can identify Definitive Healthcare position entry and exit signals to maximize returns.
Definitive Healthcare Return and Market Media
The median price of Definitive Healthcare for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 4.35 with a coefficient of variation of 3.66. The daily time series for the period is distributed with a sample standard deviation of 0.16, arithmetic mean of 4.37, and mean deviation of 0.13. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 14495 shares by William Moschella of Definitive Healthcare at 3.95 subject to Rule 16b-3 | 09/06/2024 |
2 | Disposition of 1044 shares by Shamsuddin Kate Marie of Definitive Healthcare at 4.44 subject to Rule 16b-3 | 09/13/2024 |
3 | Dartmouth Health launches paediatric care management platform | 09/25/2024 |
4 | Acquisition by Shamsuddin Kate Marie of 113379 shares of Definitive Healthcare subject to Rule 16b-3 | 09/27/2024 |
5 | Disposition of 2649 shares by Jason Krantz of Definitive Healthcare at 9.03 subject to Rule 16b-3 | 10/18/2024 |
6 | Definitive Healthcare Announces Timing of Its Third Quarter 2024 Financial Results Conference Call and Webcast | 10/24/2024 |
7 | Disposition of 7830 shares by Jason Krantz of Definitive Healthcare at 4.18 subject to Rule 16b-3 | 11/01/2024 |
8 | Acquisition by Richard Booth of 92379 shares of Definitive Healthcare subject to Rule 16b-3 | 11/05/2024 |
9 | Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024 | 11/07/2024 |
10 | Definitive Healthcare Corp Q3 2024 Earnings Call Highlights Navigating Revenue Challenges ... | 11/08/2024 |
11 | Definitive Healthcare Releases FY 2024 Earnings Guidance | 11/11/2024 |
12 | DH or PRVA Which Is the Better Value Stock Right Now - MSN | 11/20/2024 |
About Definitive Healthcare Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Definitive or other stocks. Alpha measures the amount that position in Definitive Healthcare has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.003065 | 0.0116 | 0.011 | 0.0115 | Price To Sales Ratio | 15.96 | 4.99 | 4.46 | 4.24 |
Definitive Healthcare Upcoming Company Events
As portrayed in its financial statements, the presentation of Definitive Healthcare's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Definitive Healthcare's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Definitive Healthcare's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Definitive Healthcare. Please utilize our Beneish M Score to check the likelihood of Definitive Healthcare's management manipulating its earnings.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Definitive Healthcare
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Definitive Healthcare Backtesting, Definitive Healthcare Valuation, Definitive Healthcare Correlation, Definitive Healthcare Hype Analysis, Definitive Healthcare Volatility, Definitive Healthcare History and analyze Definitive Healthcare Performance. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Definitive Healthcare technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.